{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:04:41Z","timestamp":1784891081796,"version":"3.55.0"},"reference-count":70,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:bold>Purpose:<\/jats:bold> Prolyl 4-hydroxylase subunit alpha 3 (<jats:italic>P4HA3<\/jats:italic>) is implicated in several cancers\u2019 development. However, <jats:italic>P4HA3<\/jats:italic> has not been reported in other cancers, and the exact mechanism of action is currently unknown.<\/jats:p><jats:p><jats:bold>Materials and methods:<\/jats:bold> First, the expression profile of <jats:italic>P4HA3<\/jats:italic> was analyzed using a combination of the University of California Santa Cruz (UCSC) database, Cancer Cell Line Encyclopedia (CCLE) database, and Genotype-Tissue Expression (GTEx) database. UniCox and Kaplan-Meier were used to analyze the predictive value of <jats:italic>P4HA3<\/jats:italic>. The expression of <jats:italic>P4HA3<\/jats:italic> was analyzed in clinical staging, immune subtypes, and Molecular subtypes. Secondly, the correlation of <jats:italic>P4HA3<\/jats:italic> with immunomodulatory genes, immune checkpoint genes, RNA modification genes, immune cell infiltration, cancer-related functional status, tumor stemness index, DNA mismatch repair (MMR) genes and DNA Methyltransferase was examined. The role of <jats:italic>P4HA3<\/jats:italic> in DNA methylation, copy number variation (CNV), mutational status, tumor mutational burden (TMB), and microsatellite instability (MSI) was also analyzed. In addition, gene set enrichment analysis (GSEA) was used to explore the potential functional mechanisms of <jats:italic>P4HA3<\/jats:italic> in pan-cancer. Finally, <jats:italic>P4HA3<\/jats:italic>-related drugs were searched in CellMiner, Genomics of Drug Sensitivity in Cancer (GDSC), and Cancer Therapeutics Response Portal (CTRP) databases.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold>: <jats:italic>P4HA3<\/jats:italic> is significantly overexpressed in most cancers and is associated with poor prognosis. <jats:italic>P4HA3<\/jats:italic> is strongly associated with clinical cancer stage, immune subtypes, molecular subtypes, immune regulatory genes, immune checkpoint genes, RNA modifier genes, immune cell infiltration, cancer-related functional status, tumor stemness index, MMR Gene, DNA Methyltransferase, DNA methylation, CNV, mutational status, TMB, and MSI are closely related. Available enrichment analysis revealed that <jats:italic>P4HA3<\/jats:italic> is associated with the epithelial-mesenchymal transition and immune-related pathways. There are currently 20 drugs associated with <jats:italic>P4HA3<\/jats:italic>.<\/jats:p><jats:p><jats:bold>Conclusion<\/jats:bold>: In human pan-cancer, <jats:italic>P4HA3<\/jats:italic> is associated with poor patient prognosis and multiple immune cells and may be a novel immunotherapeutic target. It may act on tumor progression through the epithelial-mesenchymal transition (EMT) pathway.<\/jats:p>","DOI":"10.3389\/fgene.2023.1045061","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T05:43:50Z","timestamp":1679463830000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Systematic pan-cancer analysis of the potential tumor diagnosis and prognosis biomarker P4HA3"],"prefix":"10.3389","volume":"14","author":[{"given":"Yinteng","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Nong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel Alarc\u00f2n","family":"Rodr\u00ecguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenliang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruqiong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7427","DOI":"10.1158\/1078-0432.CCR-03-0825","article-title":"Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma","volume":"10","author":"Armstrong","year":"2004","journal-title":"Clin. cancer Res. official J. Am. Assoc. Cancer Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.jid.2018.10.038","article-title":"Collagen prolyl hydroxylases are bifunctional growth regulators in melanoma","volume":"139","author":"Atkinson","year":"2019","journal-title":"J. investigative dermatology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12929-018-0426-4","article-title":"Cancer stem cells as key drivers of tumour progression","volume":"25","author":"Ayob","year":"2018","journal-title":"J. Biomed. Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e000381","DOI":"10.1136\/jitc-2019-000381","article-title":"Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: A multicohort study","volume":"8","author":"Bai","year":"2020","journal-title":"J. Immunother. cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrm3904","article-title":"Remodelling the extracellular matrix in development and disease","volume":"15","author":"Bonnans","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41419-021-03490-5","article-title":"Exosomes in ovarian cancer ascites promote epithelial-mesenchymal transition of ovarian cancer cells by delivery of miR-6780b-5p","volume":"12","author":"Cai","year":"2021","journal-title":"Cell death Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/path.5422","article-title":"Molecular pathology of Lynch syndrome","volume":"250","author":"Cerretelli","year":"2020","journal-title":"J. pathology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.cllc.2018.09.008","article-title":"Association of tumor mutational burden with DNA repair mutations and response to anti-PD-1\/PD-L1 therapy in non-small-cell lung cancer","volume":"20","author":"Chae","year":"2019","journal-title":"Clin. lung cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1038\/s41467-018-06654-8","article-title":"TGF-\u03b2-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure","volume":"9","author":"Chakravarthy","year":"2018","journal-title":"Nat. Commun."},{"key":"B10","doi-asserted-by":"publisher","first-page":"664845","DOI":"10.3389\/fimmu.2021.664845","article-title":"CD2 is a novel immune-related prognostic biomarker of invasive breast carcinoma that modulates the tumor microenvironment","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.ccell.2022.06.011","article-title":"Oncogenic collagen I homotrimers from cancer cells bind to \u03b13\u03b21 integrin and impact tumor microbiome and immunity to promote pancreatic cancer","volume":"40","author":"Chen","year":"2022","journal-title":"Cancer Cell"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1158\/0008-5472.CAN-18-2070","article-title":"Collagen prolyl hydroxylation-dependent metabolic perturbation governs epigenetic remodeling and mesenchymal transition in pluripotent and cancer cells","volume":"79","author":"D'Aniello","year":"2019","journal-title":"Cancer Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41571-020-0403-1","article-title":"TGF\u03b2 biology in cancer progression and immunotherapy","volume":"18","author":"Derynck","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1158\/1078-0432.CCR-15-1678","article-title":"Microsatellite instability as a biomarker for PD-1 blockade","volume":"22","author":"Dudley","year":"2016","journal-title":"Clin. cancer Res. official J. Am. Assoc. Cancer Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.3390\/cancers12082300","article-title":"Exosomes-Mediated transfer of Itga2 promotes migration and invasion of prostate cancer cells by inducing epithelial-mesenchymal transition","volume":"12","author":"Gaballa","year":"2020","journal-title":"Cancers"},{"key":"B16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1080\/10409238.2016.1269716","article-title":"Molecular insights into prolyl and lysyl hydroxylation of fibrillar collagens in health and disease","volume":"52","author":"Gjaltema","year":"2017","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3109\/10409231003627991","article-title":"Prolyl 4-hydroxylase","volume":"45","author":"Gorres","year":"2010","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"6694","DOI":"10.1002\/cam4.3324","article-title":"TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma","volume":"9","author":"Guo","year":"2020","journal-title":"Cancer Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"669750","DOI":"10.3389\/fimmu.2021.669750","article-title":"Comprehensive analysis of PD-L1 expression, immune infiltrates, and m6A RNA methylation regulators in esophageal squamous cell carcinoma","volume":"12","author":"Guo","year":"2021","journal-title":"Front. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-0916-x","article-title":"Anti-tumour immunity controlled through mRNA m(6)A methylation and YTHDF1 in dendritic cells","volume":"566","author":"Han","year":"2019","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/bjc.2012.380","article-title":"The collagen prolyl hydroxylases are novel transcriptionally silenced genes in lymphoma","volume":"107","author":"Hatzimichael","year":"2012","journal-title":"Br. J. cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.1073\/pnas.92.10.4427","article-title":"Cloning, baculovirus expression, and characterization of a second mouse prolyl 4-hydroxylase alpha-subunit isoform: Formation of an alpha 2 beta 2 tetramer with the protein disulfide-isomerase\/beta subunit","volume":"92","author":"Helaakoski","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1801946","article-title":"Nivolumab plus ipilimumab in lung cancer with a high tumor mutational burden","volume":"378","author":"Hellmann","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1186\/s12885-022-09595-0","article-title":"The oncogenic role of tubulin alpha-1c chain in human tumours","volume":"22","author":"Hu","year":"2022","journal-title":"BMC cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"812713","DOI":"10.3389\/fimmu.2021.812713","article-title":"Insights into the prognostic value and immunological role of NAAA in pan-cancer","volume":"12","author":"Huang","year":"2021","journal-title":"Front. Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1038\/psp.2013.56","article-title":"Application of ggplot2 to pharmacometric graphics","volume":"2","author":"Ito","year":"2013","journal-title":"CPT pharmacometrics Syst. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3580719","DOI":"10.1155\/2020\/3580719","article-title":"NFE2L2 is a potential prognostic biomarker and is correlated with immune infiltration in brain lower grade glioma: A pan-cancer analysis","volume":"2020","author":"Ju","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ccell.2022.05.004","article-title":"Spatiotemporal co-dependency between macrophages and exhausted CD8(+) T cells in cancer","volume":"40","author":"Kersten","year":"2022","journal-title":"Cancer Cell"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4662","DOI":"10.1158\/0008-5472.CAN-05-2804","article-title":"Collagen type I induces disruption of E-cadherin-mediated cell-cell contacts and promotes proliferation of pancreatic carcinoma cells","volume":"66","author":"Koenig","year":"2006","journal-title":"Cancer Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.gene.2018.09.052","article-title":"Cancer stem cells: A brief review of the current status","volume":"681","author":"Ku\u015fo\u011flu","year":"2019","journal-title":"Gene"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41591-018-0096-5","article-title":"Phenotype molding of stromal cells in the lung tumor microenvironment","volume":"24","author":"Lambrechts","year":"2018","journal-title":"Nat. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s43018-022-00411-z","article-title":"Cancer-associated fibroblasts in the single-cell era","volume":"3","author":"Lavie","year":"2022","journal-title":"Nat. cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"7413","DOI":"10.1158\/1078-0432.CCR-19-0558","article-title":"Combination of TMB and CNA stratifies prognostic and predictive responses to immunotherapy across metastatic cancer","volume":"25","author":"Liu","year":"2019","journal-title":"Clin. cancer Res. official J. Am. Assoc. Cancer Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"8845","DOI":"10.18632\/aging.102300","article-title":"COL6A6 interacted with P4HA3 to suppress the growth and metastasis of pituitary adenoma via blocking PI3K-Akt pathway","volume":"11","author":"Long","year":"2019","journal-title":"Aging"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1093\/jnci\/dji311","article-title":"DNA methyltransferase inhibitors and the development of epigenetic cancer therapies","volume":"97","author":"Lyko","year":"2005","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.12688\/f1000research.16409.2","article-title":"gganatogram: An R package for modular visualisation of anatograms and tissues based on ggplot2","volume":"7","author":"Maag","year":"2018","journal-title":"F1000Research"},{"key":"B37","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","article-title":"Machine learning identifies stemness features associated with oncogenic dedifferentiation","volume":"173","author":"Malta","year":"2018","journal-title":"Cell"},{"key":"B38","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/s42003-021-02323-7","article-title":"TGF-\u03b2-dependent reprogramming of amino acid metabolism induces epithelial-mesenchymal transition in non-small cell lung cancers","volume":"4","author":"Nakasuka","year":"2021","journal-title":"Commun. Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"4520","DOI":"10.1038\/s41467-020-18298-8","article-title":"Collagen promotes anti-PD-1\/PD-L1 resistance in cancer through LAIR1-dependent CD8(+) T cell exhaustion","volume":"11","author":"Peng","year":"2020","journal-title":"Nat. Commun."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1038\/onc.2016.358","article-title":"ZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasis","volume":"36","author":"Peng","year":"2017","journal-title":"Oncogene"},{"key":"B42","doi-asserted-by":"publisher","first-page":"5416923","DOI":"10.1155\/2018\/5416923","article-title":"Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment","volume":"2018","author":"Phi","year":"2018","journal-title":"Stem Cells Int."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","article-title":"Immune checkpoint blockade in cancer therapy","volume":"33","author":"Postow","year":"2015","journal-title":"J. Clin. Oncol. official J. Am. Soc. Clin. Oncol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1111\/cas.14078","article-title":"Tumor-associated macrophages promote bladder tumor growth through PI3K\/AKT signal induced by collagen","volume":"110","author":"Qiu","year":"2019","journal-title":"Cancer Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.cell.2017.05.045","article-title":"Dynamic RNA modifications in gene expression regulation","volume":"169","author":"Roundtree","year":"2017","journal-title":"Cell"},{"key":"B46","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1165\/rcmb.2007-0071OC","article-title":"Collagen I promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor-beta signaling","volume":"38","author":"Shintani","year":"2008","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1042\/EBC20190037","article-title":"The DNA methylation landscape in cancer","volume":"63","author":"Skvortsova","year":"2019","journal-title":"Essays Biochem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1533033818796485","DOI":"10.1177\/1533033818796485","article-title":"P4HA3 is epigenetically activated by slug in gastric cancer and its deregulation is associated with enhanced metastasis and poor survival","volume":"17","author":"Song","year":"2018","journal-title":"Technol. cancer Res. Treat."},{"key":"B49","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA a cancer J. Clin."},{"key":"B50","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1161\/01.CIR.0000080883.53863.5C","article-title":"Cloning of a novel prolyl 4-hydroxylase subunit expressed in the fibrous cap of human atherosclerotic plaque","volume":"108","author":"Van Den Diepstraten","year":"2003","journal-title":"Circulation"},{"key":"B51","doi-asserted-by":"publisher","first-page":"10403","DOI":"10.1021\/acs.jmedchem.8b00822","article-title":"Collagen prolyl 4-hydroxylase as a therapeutic target","volume":"61","author":"Vasta","year":"2018","journal-title":"J. Med. Chem."},{"key":"B52","doi-asserted-by":"publisher","first-page":"7467","DOI":"10.1073\/pnas.89.16.7467","article-title":"Characterization of the human prolyl 4-hydroxylase tetramer and its multifunctional protein disulfide-isomerase subunit synthesized in a baculovirus expression system","volume":"89","author":"Vuori","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B53","doi-asserted-by":"publisher","first-page":"104711","DOI":"10.1016\/j.archoralbio.2020.104711","article-title":"Prolyl 4-hydroxylase subunit alpha 3 presents a cancer promotive function in head and neck squamous cell carcinoma via regulating epithelial-mesenchymal transition","volume":"113","author":"Wang","year":"2020","journal-title":"Arch. Oral Biol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The cancer Genome Atlas pan-cancer analysis project","volume":"45","author":"Weinstein","year":"2013","journal-title":"Nat. Genet."},{"key":"B55","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1158\/1078-0432.CCR-14-1051","article-title":"Desmoplasia in primary tumors and metastatic lesions of pancreatic cancer","volume":"21","author":"Whatcott","year":"2015","journal-title":"Clin. cancer Res. official J. Am. Assoc. Cancer Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"357","DOI":"10.20517\/2394-4722.2016.08","article-title":"Function of cancer cell-derived extracellular matrix in tumor progression","volume":"2","author":"Xiong","year":"2016","journal-title":"J. Cancer Metastasis Treat."},{"key":"B57","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1172\/JCI93554","article-title":"The fibrotic tumor stroma","volume":"128","author":"Yamauchi","year":"2018","journal-title":"J. Clin. investigation"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1111\/cas.13624","article-title":"Collagen type I induces EGFR-TKI resistance in EGFR-mutated cancer cells by mTOR activation through Akt-independent pathway","volume":"109","author":"Yamazaki","year":"2018","journal-title":"Cancer Sci."},{"key":"B59","first-page":"751","article-title":"Hepatic stellate cells secretes type I collagen to trigger epithelial mesenchymal transition of hepatoma cells","volume":"4","author":"Yang","year":"2014","journal-title":"Am. J. cancer Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1056\/NEJMc1713444","article-title":"Tumor mutational burden and response rate to PD-1 inhibition","volume":"377","author":"Yarchoan","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"Omics a J. Integr. Biol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.it.2020.06.008","article-title":"Rewriting history: Epigenetic reprogramming of CD8(+) T cell differentiation to enhance immunotherapy","volume":"41","author":"Zebley","year":"2020","journal-title":"Trends Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12943-019-0959-5","article-title":"Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT","volume":"18","author":"Zhang","year":"2019","journal-title":"Mol. cancer"},{"key":"B64","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrm.2016.132","article-title":"Post-transcriptional gene regulation by mRNA modifications","volume":"18","author":"Zhao","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"650023","DOI":"10.3389\/fcell.2021.650023","article-title":"m6A regulators is differently expressed and correlated with immune response of esophageal cancer","volume":"9","author":"Zhao","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-019-0738-1","article-title":"Mismatch repair deficiency\/microsatellite instability-high as a predictor for anti-PD-1\/PD-L1 immunotherapy efficacy","volume":"12","author":"Zhao","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"95586","DOI":"10.18632\/oncotarget.21525","article-title":"Collagen I promotes hepatocellular carcinoma cell proliferation by regulating integrin \u03b21\/FAK signaling pathway in nonalcoholic fatty liver","volume":"8","author":"Zheng","year":"2017","journal-title":"Oncotarget"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1542117","DOI":"10.1155\/2022\/1542117","article-title":"miR-1266-3p suppresses epithelial-mesenchymal transition in colon cancer by targeting P4HA3","volume":"2022","author":"Zhou","year":"2022","journal-title":"Anal. Cell. Pathol. Amst."},{"key":"B69","doi-asserted-by":"publisher","first-page":"153749","DOI":"10.1016\/j.prp.2021.153749","article-title":"Prolyl 4-hydroxylase subunit alpha 3 facilitates human colon cancer growth and metastasis through the TGF-\u03b2\/Smad signaling pathway","volume":"230","author":"Zhou","year":"2022","journal-title":"Pathology, Res. Pract."},{"key":"B70","doi-asserted-by":"publisher","first-page":"687778","DOI":"10.3389\/fgene.2021.687778","article-title":"Pan-cancer analysis of PIMREG as a biomarker for the prognostic and immunological role","volume":"12","author":"Zhu","year":"2021","journal-title":"Front. Genet."}],"updated-by":[{"DOI":"10.3389\/fgene.2023.1204421","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000}}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2023.1045061\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T07:50:35Z","timestamp":1684828235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2023.1045061\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,22]]},"references-count":70,"alternative-id":["10.3389\/fgene.2023.1045061"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2023.1045061","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fgene.2023.1204421","asserted-by":"object"}]},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,22]]},"article-number":"1045061"}}